Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
Status:
Recruiting
Trial end date:
2022-12-10
Target enrollment:
Participant gender:
Summary
Post-inflammatory hyperpigmentation is a common pigmentary skin disorder that is refractory
to treatment. The treatment for postinflammatory hyperpigmentation is limited. Recent studies
have shown that the topical skin care product cysteamine cream has a significant decrease in
melanin index without obvious side effects in other dark spots such as melasma. The goal of
this study is to determine the safety and efficacy of topical cysteamine in the treatment of
post-inflammatory hyperpigmentation.